Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 29-36

  Zheng, Zhi Ming ^a   Pei Jun, H E ^a,b   Baker, Carl C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; MESSENGER RNA PRECURSOR; PURINE; PYRIMIDINE; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DROSOPHILA; ENHANCER REGION; EXON; HUMAN IMMUNODEFICIENCY VIRUS; MUTATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; ROUS SARCOMA ONCOVIRUS; SUPPRESSOR GENE;

EID: 17344362948     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.29-36.1999     Document Type: Article

References (15)

1. Amendt, B. A., D. Hesslein, L.-J. Chang, and C. M. Stoltzfus. 1994. Presence of negative and positive cis-acting RNA splicing elements within the flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 14:3960-3970.
2. Amendt, B. A., Z.-H. Si, and C. M. Stoltzfus. 1995. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15:4606-4615.
3. 2443 and late promoters. J. Virol. 67:5605-5616.
4. Barksdale, S. K., and C. C. Baker. 1995. Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J. Virol. 69:6553-6556.
5. Bisaillon, M., and G. Lemay. 1997. Viral and cellular enzymes involved in synthesis of mRNA cap structure. Virology 236:1-7.
6. Caputi, M., G. Casari, S. Guenzi, K. Tagliabue, A. Sidoli, C. A. Melo, and F. E. Baralle. 1994. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22:1018-1022.
7. Colgan, D. F., and J. L. Manley. 1997. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11:2755-2766.
8. Del Gatto, F., and R. Breathnach. 1995. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 15:4825-4834.
9. Del Gatto, F., M. C. Gesnel, and R. Breathnach. 1996. The exon sequence TAGG can inhibit splicing. Nucleic Acids Res. 24:2017-2021.
10. Fu, X. D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1:663-680.
11. Furdon, P. J., and R. Kole. 1988. The length of the downstream exon and the substitution of specific sequences affect pre-mRNA splicing in vitro. Mol. Cell. Biol. 8:860-866.
12. Gorlich, D., and I. W. Mattaj. 1996. Nucleocytoplasmic transport. Science 271:1513-1518.
13. Krainer, A. R., T. Maniatis, B. Ruskin, and M. R. Green. 1984. Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell 36:993-1005.
14. Lavigeur, A., H. La Branche, A. R. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:2405-2417.
15. Manley, J. L., and R. Tacke. 1996. SR proteins and splicing control. Genes Dev. 10:1569-1579.